Current Protocols in Neuroscience · 1999 · 44 citations · 39 references
Life SciencesNeurobiologyNeuroscienceNeurobiology Of DiseaseNeurochemistryNeurodegenerationMonoamine NeurochemistryNeurodegenerative DiseasesNeurodegenerative DisordersNeurotransmissionParkinson DiseaseParkinsonian DisordersDopamine-related Movement DisordersDopaminergic NeurodegenerationDopaminergic Neuron DeathDopaminergic NeuronsNigrostriatal Dopamine SystemParkinson's Disease ModelsParkinsonian DegenerationStriatal Dopamine Function
Parkinson's disease is a neurodegenerative disease in which pigmented midbrain neurons progressively die producing a dopamine (DA) deficit in the striatum which manifests as an akinetic movement disorder. Experimentally induced striatal DA depletion in animals is a valid model of parkinsonism. The capacity of certain substances to damage catecholaminergic neurones has been used for a long time to produce DA deficiency in animals. This unit focuses on methods for inducing parkinsonism using the neurotoxins MPTP and 6-hydroxy dopamine and methods for evaluating the animals. Other models are briefly reviewed.
39
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
Julian Fearnley, Andrew J. Lees · Brain · 1991 · 3.5K citations
Richard S. Burns, Chuang C. Chiueh, Sanford P. Markey et al. · Proceedings of the National Academy of Sciences · 1983 · 2.1K citations · Full text
Medicine, Neuroscience, Pharmacology +17
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Glenn C. Davis, Adrian Williams, Sanford P. Markey et al. · Psychiatry Research · 1979 · 1.4K citations
Medicine, Neurology, Pharmacology +16